For research use only. Not for therapeutic Use.
Telisotuzumab（Cat No.:I042205）is a monoclonal antibody that targets and binds to the protein Trop-2, which is overexpressed in several types of cancer, including non-small cell lung cancer (NSCLC) and other solid tumors. Trop-2 is involved in promoting tumor growth and survival, and by targeting it, telisotuzumab aims to block these processes and stimulate an immune response against cancer cells. It is being investigated in clinical trials for its safety and efficacy, particularly in combination with other treatments, as a potential therapy for patients with Trop-2-positive cancers.
| Catalog Number | I042205 |
| CAS Number | 1781223-80-0 |
| Purity | ≥95% |
